Kidney And Urinary Diseases

Nov 23, 2020| Posted in: Congenital And Genetic Conditions, Kidney And Urinary Diseases, Metabolic Disorders

FDA Approves Lumasiran to Treat Primary Hyperoxaluria Type 1

Pritesh J. Gandhi, PharmD of Alnylam Pharmaceuticals provides an…
Nov 23, 2020| Posted in: Congenital And Genetic Conditions, Kidney And Urinary Diseases, Metabolic Disorders

Alnylam, and the PH1 Community, Waiting for the FDA to Approve Lumasiran

Pritesh J. Gandhi, PharmD of Alnylam Pharmaceuticals discusses the…
Nov 10, 2020| Posted in: Autoimmune / Autoinflammatory Disorders, Drug Development, Kidney And Urinary Diseases

Clinical Trials for Lupus Nephritis

Richard A. Furie, MD, from Northwell Health explains…

TTR Amyloidosis CME Program

Morie A Gertz, MD, MACP provides an overview of TTR Amyloidosis – including how to shorten individuals’ diagnostic journey and the time till they access treatment which might improve their quality of life or even prevent disease progression – through these brief courses that are certified for CME credit.

CME Program: Fabry Disease Highlights from WORLDSymposium 2020

Ozlem Goker-Alpan, MD highlights the latest Fabry disease information from the WORLDSymposium and provides expert analysis of its clinical relevance for members of the care team in order to help them care for patients with this rare disease.

WHIM Syndrome Learning Center

WHIM syndrome is a rare, congenital primary immunodeficiency disorder associated with severe neutropenia that affects all ages. However, due to the heterogeneous presentation of the disease, coupled with lack of awareness of the condition, the diagnosis may be delayed, sometimes even into adulthood.

Kidney And Urinary Diseases

Topics